Furthermore, in neuroblastoma cells, it was noted that miR-1303 targets both glycogen synthase kinase-3 beta (GSK3β) and secreted frizzled-related protein 1 (SFRP1), which are endogenous inhibitors of Wnt/β-catenin. Here, GSK3B is linked to neuroblastoma.